Allogeneic Stem Cell Transplantation in Patients Aged ≥70 Years: Epidemiology, Outcomes, and Risk Factors Based on the German Registry for Stem Cell Transplantation (DRST)

Jan Frederic Weller, Louisa Kaufmann,Claudia Lengerke,Jürgen Finke,Johannes Schetelig,Uwe Platzbecker,Hermann Einsele,Dietrich W. Beelen,Christoph Faul,Matthias Stelljes,Peter Dreger,Igor Wolfgang Blau,Gerald Wulf,Johanna Tischer,Christof Scheid,Ahmet Elmaagacli,Helga Neidlinger,Sandra Frank,Martin Bornhäuser,Wolfgang A Bethge

Blood（2021）

引用 0|浏览2

暂无评分

摘要

Introduction. Malignant diseases treated with allogeneic hematopoietic stem cell transplantation (alloHSCT) predominantly occur beyond the 7 th decade of life. Numerical age per se is not regarded an adverse risk factor in alloHSCT. In an aging society, interventions historically deemed high risk are increasingly used in elder patients.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要